RecruitingNot ApplicableNCT05995431

Impact of Bruxism in the Outcome of Subgingival Instrumentation for the Management of Stage 2 and Stage 3 Periodontitis.

Impact of Bruxism in the Outcome of Subgingival Instrumentation for the Management of Stage 2 and Stage 3 Periodontitis: A Comparative Interventional Study.


Sponsor

Postgraduate Institute of Dental Sciences Rohtak

Enrollment

58 participants

Start Date

Sep 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Bruxism is a multifaceted phenomenon that has been associated with several factors mediated by the central nervous system3. Bruxism is an umbrella term grouping different motor phenomenon. 'Bruxism is a repetitive jaw-muscle activity characterized by clenching or grinding of the teeth and/or by bracing or thrusting of the mandible. Bruxism has two distinct circadian manifestations: it can occur during sleep (indicated as sleep bruxism) or during wakefulness (indicated as awake bruxism5. Sleep bruxism is considered to be a putative exacerbating factor, rather than a causative factor of periodontal disease and night-guards have been used as a counter measure. Since the periodontium in sleep bruxism patients suffers from excessive occlusal force for long periods of time during sleep, the function of the periodontium in such patients may differ from that in patients without sleep bruxism. Awake bruxism is defined as masticatory muscle activity during wakefulness that is characterized by repetitive or sustained tooth contact and by bracing or thrusting of the mandible.Given the potential impact of abnormal forces on the periodontium, understanding the relationship between bruxism and periodontal disease is crucial for the prevention and management of these conditions. This study aims to explore the mechanisms by which bruxism affects the periodontium and to assess the impact of bruxism in the outcome of subgingival instrumentation for the management of Stage 2 and Stage 3 periodontitis.


Eligibility

Min Age: 30 YearsMax Age: 50 Years

Inclusion Criteria9

  • TEST GROUP
  • Systemically healthy patients
  • Patient having stage 2 or stage 3 periodontitis with bruxism Age between 30-50 years
  • Minimum 20 teeth present in oral cavity
  • CONTROL GROUP
  • Systemically healthy patients
  • Patient having stage 2 or stage 3 periodontitis without bruxism
  • Age between 30-50 years
  • Minimum 20 teeth present in oral cavity

Exclusion Criteria3

  • History of systemic disease such as diabetes or autoimmune disease
  • History of drugs having the potential impact on periodontal status like phenytoin, cyclosporin, calcium-channel blockers or antidepressant drugs
  • Pregnant or lactating females

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREscaling and root planing

All the participants will undergo scaling and root planing

PROCEDURESubgingival instrumentation

All the participants will undergo subgingival instrumentation


Locations(1)

Post Graduate Institute of Dental Sciences

Rohtak, Haryana, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05995431


Related Trials